May 14 |
Allogene (ALLO) Q1 Earnings in Line With Estimates, Sales Lag
|
May 14 |
Novo Nordisk (NVO) Up 3% as Haemophilia Drug Meets Study Goals
|
May 14 |
Merck (MRK) Ends Keytruda Combo Melanoma Study Due to Futility
|
May 14 |
Bayer (BAYRY) Q1 Earnings Fall Y/Y on Lower Product Sales
|
May 13 |
Ligand (LGND) Moves to Strong Buy: Rationale Behind the Upgrade
|
May 13 |
Moderna (MRNA) Falls as FDA Extends Review Time for RSV Vaccine
|
May 13 |
Bristol Myers (BMY) Fails to Meet Goal in Opdivo NSCLC Study
|
May 10 |
Nektar's (NKTR) Q1 Earnings and Revenues Surpass Estimates
|
May 10 |
Insmed (INSM) Beats on Q1 Earnings, Posts Upbeat Pipeline Updates
|
May 10 |
Iovance (IOVA) Q1 Earnings Surpass, Sales Lag Estimates
|